Brief: Immunovia Receives Final Medicare Payment Rate For Pancreasure Test
26/11/2025 15:24
Nov 26 (Reuters) - Immunovia AB (publ) IMMNOV.ST: RECEIVES FINAL MEDICARE PAYMENT RATE FOR PANCREASURE TEST CMS HAS FINALIZED A NATIONAL PAYMENT RATE OF $897 FOR PANCREASURE TEST EFFECTIVE JAN 1, 2026, THIS REPRESENTS SECOND OF THREE STEPS ON PATH TO MEDICARE REIMBURSEMENT Source text: ID:nMFN7bD5Gd Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))